Brookdale Senior Living Past Earnings Performance
Past criteria checks 0/6
Brookdale Senior Living's earnings have been declining at an average annual rate of -20.8%, while the Healthcare industry saw earnings growing at 7.2% annually. Revenues have been declining at an average rate of 3.3% per year.
Key information
-20.8%
Earnings growth rate
-17.2%
EPS growth rate
| Healthcare Industry Growth | 15.7% |
| Revenue growth rate | -3.3% |
| Return on equity | -71.1% |
| Net Margin | -7.1% |
| Last Earnings Update | 30 Sep 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How Brookdale Senior Living makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 24 | 2,955 | -209 | 394 | 0 |
| 30 Jun 24 | 2,921 | -207 | 393 | 0 |
| 31 Mar 24 | 2,898 | -174 | 391 | 0 |
| 31 Dec 23 | 2,867 | -189 | 385 | 0 |
| 30 Sep 23 | 2,809 | -123 | 371 | 0 |
| 30 Jun 23 | 2,742 | -103 | 357 | 0 |
| 31 Mar 23 | 2,676 | -183 | 344 | 0 |
| 31 Dec 22 | 2,598 | -238 | 339 | 0 |
| 30 Sep 22 | 2,727 | -294 | 339 | 0 |
| 30 Jun 22 | 2,678 | -92 | 343 | 0 |
| 31 Mar 22 | 2,713 | -91 | 359 | 0 |
| 31 Dec 21 | 2,564 | -99 | 372 | 0 |
| 30 Sep 21 | 2,643 | -62 | 379 | 0 |
| 30 Jun 21 | 2,746 | -361 | 395 | 0 |
| 31 Mar 21 | 2,805 | -396 | 412 | 0 |
| 31 Dec 20 | 3,424 | 82 | 450 | 0 |
| 30 Sep 20 | 3,145 | 35 | 458 | 0 |
| 30 Jun 20 | 3,254 | 81 | 478 | 0 |
| 31 Mar 20 | 3,333 | 144 | 490 | 0 |
| 31 Dec 19 | 3,267 | -268 | 508 | 0 |
| 30 Sep 19 | 3,282 | -45 | 507 | 0 |
| 30 Jun 19 | 3,326 | -4 | 509 | 0 |
| 31 Mar 19 | 3,421 | -114 | 519 | 0 |
| 31 Dec 18 | 3,521 | -528 | 563 | 0 |
| 30 Sep 18 | 3,622 | -645 | 549 | 0 |
| 30 Jun 18 | 3,705 | -1,022 | 571 | 0 |
| 31 Mar 18 | 3,748 | -902 | 583 | 0 |
| 31 Dec 17 | 3,856 | -571 | 618 | 0 |
| 30 Sep 17 | 3,961 | -855 | 605 | 0 |
| 30 Jun 17 | 4,078 | -493 | 606 | 0 |
| 31 Mar 17 | 4,194 | -482 | 621 | 0 |
| 31 Dec 16 | 4,239 | -404 | 637 | 0 |
| 30 Sep 16 | 4,265 | -310 | 645 | 0 |
| 30 Jun 16 | 4,262 | -327 | 651 | 0 |
| 31 Mar 16 | 4,248 | -376 | 616 | 0 |
| 31 Dec 15 | 4,237 | -457 | 630 | 0 |
| 30 Sep 15 | 4,240 | -390 | 623 | 0 |
| 30 Jun 15 | 4,151 | -358 | 615 | 0 |
| 31 Mar 15 | 3,753 | -277 | 595 | 0 |
| 31 Dec 14 | 3,344 | -149 | 525 | 0 |
| 30 Sep 14 | 2,931 | -43 | 484 | 0 |
| 30 Jun 14 | 2,604 | -8 | 448 | 0 |
| 31 Mar 14 | 2,572 | -9 | 447 | 0 |
| 31 Dec 13 | 2,546 | -4 | 447 | 0 |
Quality Earnings: B7S is currently unprofitable.
Growing Profit Margin: B7S is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: B7S is unprofitable, and losses have increased over the past 5 years at a rate of 20.8% per year.
Accelerating Growth: Unable to compare B7S's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: B7S is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (40.5%).
Return on Equity
High ROE: B7S has a negative Return on Equity (-71.09%), as it is currently unprofitable.